FREE CONSULTATION (713) 621-7944


Johnson & Johnson ASR Trial Testimony: Confirming Profit Came First

January 1, 1970 · FLEMING | NOLEN | JEZ, L.L.P.

In March 2012, I wrote two blogs about Johnson & Johnson’s disregard for patient safety. Again & Again: Johnson & Johnson Disregards Patient Safety and Business as Usual: Johnson & Johnson Put Profits over Patient Safety. Not surprisingly, testimony from a company witness shows just how the DePuy Orthopedics, a Johnson & Johnson company, conducted their medical device business – with profit in mind.

Mangus Felt, a leader of the ASR metal-on-metal hip implant design team, testified in the trial against DePuy Orthopedics and Johnson & Johnson. His testimony supports the alleged claims of thousands of plaintiffs around the country:

  • DePuy misled doctors by advising them to implant the ASR hip at a 45 degree angle despite knowing that the data showed a better result at 55 degree angle.
  • DePuy knew that bony ingrowth was lacking with the ASR metal-on-metal hip implant.
  • DePuy abandoned an effort to redesign the ASR metal-on-metal hip putting financial and business reasons ahead of patient safety.
  • DePuy withheld the true failure rates of the ASR metal-on-metal hip implant from surgeons because it did not believe the information was “clinically relevant.”